Product Description
Overall, the global biopsy forceps, polypectomy snare and EUS needle market was valued at $728.6 million in 2021. This is expected to increase over the forecast period at a CAGR of 3.7% to reach $942.8 million.
This full report suite includes the global market for biopsy forceps, polypectomy snares and EUS needles.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2028, and Historical Data to 2018
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
PROCEDURE NUMBERS
Growth in tissue biopsy procedures continues to be driven by the increasing number of patients who exhibited symptoms of disorders or abnormalities in their GI tract. Technological improvements in diagnostic procedures also increased demand for polyp and sample removal by biopsy forceps.
GLOBAL BIOPSY FORCEPS, POLYPECTOMY SNARES, AND EUS NEEDLE DEVICE MARKET TRENDS
Since the price of disposable biopsy forceps experienced a sharp decline several years ago, the use of these devices increased dramatically. There was a slight dip and recovery in pricing in 2020 and 2021, due to tighter budgeting throughout the COVID-19 pandemic, but pricing is expected to see a steadier decline throughout the remainder of the forecast period. The lower price is very attractive to surgeons, which results in more frequent usage of the devices, and greater unit sales.
GLOBAL BIOPSY FORCEPS, POLYPECTOMY SNARES, AND EUS NEEDLE DEVICE MARKET SHARE INSIGHTS
Overall, within the global anti-reflux device market there are three dominant competitors: Boston Scientific, Cook Medical, and Olympus.
In 2021, the leading competitor in the biopsy forceps, polypectomy snare and EUS market was Boston Scientific, with just under half of the total market share. Boston Scientific has been successful in capturing a notable position in both the biopsy forceps and EUS needle segments.
MARKET SEGMENTATION SUMMARY
-
Biopsy Forceps Market – Including:
- Cold Disposable, Hot Disposable, Cold Reusable, and Hot Reusable Biopsy Forceps.
-
Polypectomy Snare Market
-
EUS Needle Market
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2021 |
| Forecast Period | 2022-2028 |
| Historical Data | 2018-2021 |
| Quantitative Data | Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices |
| Qualitative Data | COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.
Read more about iData’s 9-Step Research Methodology |
WHY CHOOSE iDATA?
- Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
- Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
- Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
- Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.
